Impact of Inclusion of a Dog as Part of the Fibromyalgia Treatment Program

Overview

About this study

In this study the investigators hypothesize that the presence of a Mayo Clinic certified therapy dog will provide additional benefits to patients suffering from fibromyalgia currently enrolled in the Mayo Clinic Fibromyalgia Program.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients diagnosed with Fibromyalgia at our Fibromyalgia Clinic
  • Patients actively being seen at the Fibromyalgia Clinic
  • Able and willing to give informed consent
  • Able to speak English
  • Able to complete questionnaires
  • No fear or allergy of dogs

Exclusion Criteria:

  • Diagnoses of bipolar disorder, schizophrenia, or dementia
  • Individuals who decline to participate in the study
  • Individuals that are severely allergic to or fearful of dogs

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Arya Mohabbat, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20301419

Mayo Clinic Footer